Advertisement

Spine


In July, the official journal of the North American Spine Society, The Spine Journal, released an issue dedicated to the use of recombinant bone morphogenic protein. The only BMP product on the market currently approved by the FDA for promoting…

After suffering a spinal cord injury in 2004 and diagnosed with quadriplegia, Tim Hemmes has learned to control a robotic arm with his mind, using a system designed by researchers at the University of Pittsburgh, according to a Pittsburgh Post-Gazette…

A study of 1,037 patients who received recombinant bone morphogenic protein-2 to promote fusion in a posterolateral application shows the procedure is a safe and effective treatment for patients, according to a report published in Spine.

Advertisement